Company intelligence / Profile preview

Haneil Soyatech

Hwaseong-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Haneil Soyatech is a South Korean biotechnology company specializing in the research, development, and production of high-purity soy-derived bioactive compounds. The company is best known for its proprietary fermentation and extraction technologies used to produce soy isoflavones, particularly in the highly bioavailable aglycone form. Their product portfolio targets the nutraceutical and pharmaceutical industries, focusing on applications for women's health, bone density, and metabolic wellness. Haneil Soyatech provides standardized raw materials for functional foods and dietary supplements to a global market.

Therapeutic areas: EndocrinologyWomen's HealthMetabolic Disorders
Modalities: Small moleculeNatural product
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Haneil Soyatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haneil Soyatech.

Explore the full profile